Further evidence supporting conservative management for most patients with stable coronary artery disease (CAD) and angina comes from a new study of more than 30,000 patients in the prospective CLARIFY registry. Among those with angina at baseline, symptoms disappeared without…
Read More
Firmagon
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. Firmagon® Degarelix (as acetate) Powder and Solvent for Injection, depot Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Firmagon. It…
Read More
Zocor (MK)
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ZOCOR® Simvastatin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ZOCOR.It does not contain all the available information. It does…
Read More
APO-Sotalol
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-SOTALOL TABLETS Sotalol hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about sotalol. It does not contain all the available…
Read More
APO-Amisulpride
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-AMISULPRIDE Amisulpride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about amisulpride. It does not contain all the available information. It…
Read More
Arcoxia
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ARCOXIA® Etoricoxib (pronounced ee-TOR-ee-cox-ib) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ARCOXIA.It does not contain all the available information.It…
Read More